Join Us!
Lyfebulb invite you to join our patient conference, “Empowering Lives: State of Transplantation.” This event brings together everyone involved in the transplant journey—recipients, donors, care partners, doctors, and industry experts with the goal to improve the quality of life and outcomes for everyone. We’re here to share stories, learn from experts, discuss challenges, and find solutions.
Our event on October 4, 2024 at NYU Langone Health in New York City will include:
- Inspirational Talks: Hear from experts in the field of transplantation
- Engaging Panels: Join discussions on important topics from both the patient and provider perspective, such as new treatments, care management, and future innovations in transplantation
- Networking Opportunities: Connect with others who understand your journey
- Contribute to the Future: Offer your perspective through questions to panels and responses to a survey
- Peer-to-Peer Meet-Up: Meet your fellow transplant peers in a closed session led by our TransplantLyfe Community managers (patients, donors and care partners only)
Agenda
9:00 – 9:10 AM
Welcome Remarks & Introductions
9:10 – 9:30 AM
My Transplant Journey: A Recipient’s Story
9:30 – 10:00 AM
Current Treatment Paradigm
10:00 – 10:30 AM
Celebrities As a Vehicle to Influence Change in Healthcare
10:30 – 10:45 AM
Break
10:45 – 11:45 AM
Getting Better Drugs to Patients: Regulatory Environment and Clinical Endpoints
11:45 – 12:45 PM
Future of Transplantation: Xenotransplant, Tolerance, Organ Preservation, and more
12:45 – 1:45 PM
Lunch Break & Peer to Peer Meet Up
1:45 – 3:30 PM
Current Care Management: Best Care Practices, Challenges and Opportunities, and Quality of Life
3:30 – 3:45 PM
Break & Afternoon Stretch
3:45 – 4:15 PM
The TransplantLyfe365 Solution
4:15 – 5:00 PM
Closing Remarks
SPEAKERS
Nicole Ali, MD
Clinical Associate Professor, Department of Medicine at NYU Grossman School of Medicine; Director, Quality, Transplant Institute at NYU Langone Transplant Institute
Russell J. Crew, MD
Assistant Professor of Medicine at NewYork-Presbyterian / Columbia University Irving Medical Center
Michael Goldstein, MD
Director of Organ Transplantation at Hackensack University Medical Center
Mark A. Hardy, MD, PhD (Hon), FACS
Director Emeritus and Founder, Renal and Islet Transplantation, and Surgeon, Abdominal Organ Transplantation and Islets at NewYork-Presbyterian Hospital/Columbia University Medical Center
Karin Hehenberger, MD, PhD
Founder & CEO at Lyfebulb
Eliezer Katz, MD, FACS
Chief Medical Officer at Eledon Pharmaceuticals
Robert Montgomery, MD, PhD
H. Leon Pachter Chair and Professor of Surgery Director at NYU Langone Transplant Institute
Kenneth Newell, MD, PhD
Chief Medical Officer at Eledon Pharmaceuticals
Thank You To Our Supporters
Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Brought to you by
Lyfebulb
Under the leadership of Dr. Robert Montgomery, the NYU Langone Health Transplant Institute is a national leader in organ transplantation, excelling in heart, kidney, liver, and lung transplants. According to SRTR data, the institute boasts the fastest heart transplant rate in the Northeast, the top kidney program in the country, a 100% one-year liver transplant survival rate, and the highest-ranked lung transplant program in the U.S. These achievements highlight the institute’s expertise in treating complex cases.
